Starting on:
Oct 5, 2023
Ending on:
Oct 5, 2023
Moderator(s):
Center for Clinical Research, KEMRI
Max Credits:
5 Points
Provider:
KEMRI/CDC Research and Public collaboration.
Claim Points
Oct 5, 2023
Ending on:
Oct 5, 2023
Moderator(s):
Dr.
Hellen Ngeno
Moderator
Venue: Moderator
Center for Clinical Research, KEMRI
Max Credits:
5 Points
Provider:
KEMRI/CDC Research and Public collaboration.
Claim Points
Antimicrobial resistance: The scope and the hope for Kenya
Starting on:
Oct 5, 2023
Oct 5, 2023
Ending on:
Oct 5, 2023
Oct 5, 2023
Venue:
Center for Clinical Research, KEMRI
Center for Clinical Research, KEMRI
Description
Continuos medical examination
Objectives
To discuss on the Antimicrobial resistance: the scope and the hope for Kenya.
Presenters
-
Dr.
Lilian Musila
Dr. Musila is a biomedical research scientist with decades of international research, academic and teaching experience in microbiology, parasitology, human genetics, cancer, virology, developmental and molecular biology. Dr. Musila has two postdoctoral fellowships from the National Laboratory Health Services in South Africa and Emory University in Atlanta, GA, USA. She earned a Ph.D. in Molecular Parasitology from the University of Pennsylvania, Philadelphia, PA, USA, and a B.Sc. Microbiology from the University of Massachusetts, Amherst, MA, USA. Dr. Musila has worked for the past fifteen years at the Kenya Medical Research Institute, Nairobi, Kenya, for the Walter Reed Project. Her work has focussed on infectious disease surveillance and research on viral and bacterial pathogens. As the head of the Antimicrobial resistance program since 2015, she focusses on antimicrobial resistance surveillance of World Halth Organization priority pathogens to track antibiotic resistance trends and define their distribution across the country and the genes responsible for antibiotic resistance and virulence. Her other research interests are determining how multidrug-resistant bacterial pathogens are transmitted between humans, animals and their environment and identifying bacteriophages that can treat infections caused by MDR bacterial pathogens as alternatives for antibiotic. This research is conducted in partnership with global and national research partners.
KEMRI- Walter reed Project